Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy
We had great news today (Thursday), but the response was tepid. Rather than being disappointed or dismissing the news, here is why we should be excited at both the developments and the investment potential it opens up.
This article is published on SeekingAlpha.com
